Automating Bariatric Surgery GLP-1 Prior Auth Workflows

The Challenge of GLP-1 PAs in Bariatric Care

Bariatric patients frequently present with complex comorbidities and a history of supervised weight loss attempts, requiring extensive documentation for prior authorizations. When GLP-1 medications are prescribed, especially for obesity, practices face high PA volumes, frequent step-therapy gates, and a significant risk of denials due to varied payer coverage for anti-obesity medications. This burden diverts staff time from direct patient care and delays access to critical treatments.

Klivira's Automated GLP-1 Prior Auth Workflow for Bariatric Practices

Klivira's platform is engineered to navigate the specific complexities of GLP-1 prior authorizations within a bariatric surgery context. Our automation capabilities simplify the submission process, reduce manual effort, and improve approval rates for high-volume medications like Ozempic, Wegovy, Mounjaro, Zepbound, and Saxenda.

Key Automation Steps for Bariatric GLP-1 PAs:

• **Indication Classification:** Klivira intelligently identifies T2D versus obesity indications directly from EMR diagnosis codes and clinical context, critical for accurate payer routing.
• **Per-Payer Obesity-Coverage Routing:** Our policy engine maintains up-to-date information on payer obesity benefit status (covered, restricted, not-covered) to route PAs appropriately.
• **Step Therapy Documentation Automation:** We pull essential data, such as metformin trial history, BMI documentation, and comorbidity status, from your EMR via FHIR for automated step therapy compliance.
• **Brand-Specific PA Criteria:** Different GLP-1 products have distinct prior authorization requirements; Klivira applies brand-specific logic to ensure complete and accurate submissions.
• **Integrated Specialty Pharmacy Fulfillment:** Post-approval, Klivira can facilitate routing to specialty pharmacies, a common requirement for many GLP-1 products.
• **Patient Financial Counseling Integration:** In cases where obesity indications are denied, the system can surface manufacturer copay programs and alternative coverage paths to support patient access.

Seamless EMR Integration for Enhanced Efficiency

Integrating directly with your EMR system, Klivira leverages SMART on FHIR capabilities to extract relevant clinical data for GLP-1 prior authorization requests. This includes patient demographics, diagnosis codes, lab results (e.g., A1C), BMI history, and documentation of prior weight loss attempts or comorbidities. This direct data flow eliminates manual data entry, reduces errors, and ensures that all necessary medical necessity criteria are met for procedures like gastric bypass and gastric sleeve, as well as medication approvals.

Addressing Payer Variability and Clinical Guidelines

The landscape of GLP-1 coverage for obesity indications is dynamic, with significant variability across payers. Klivira's robust policy library helps bariatric practices navigate these complex rules. Our system incorporates criteria informed by clinical guidelines, such as the ADA Standards of Care for T2D treatment algorithms, to build comprehensive and compliant prior authorization requests. This proactive approach helps reduce denials and accelerate patient access to medications like Ozempic, Wegovy, Mounjaro, and Zepbound.

Impact on Revenue Cycle and Patient Outcomes

Automating GLP-1 prior authorizations for bariatric patients directly impacts your revenue cycle by reducing administrative costs, minimizing claim denials, and accelerating reimbursement. More importantly, it improves patient access to crucial medications that support weight management and overall health outcomes, aligning with the comprehensive care provided by bariatric surgery programs.